Desmopressin (DDAVP) in the treatment of bleeding disorders: The first twenty years

Haemophilia

Volumn 6, Issue SUPPL. 1, 2000, Pages 60-67

  Mannucci, P M ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b WORLD FEDERATION OF HEMOPHILIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; DESMOPRESSIN;

BLEEDING DISORDER; BLOOD TRANSFUSION; CONGENITAL DISORDER; DRUG INDUCED DISEASE; DRUG MECHANISM; HEMOPHILIA; HISTORY; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; VON WILLEBRAND DISEASE;

COAGULATION PROTEIN DISORDERS; DEAMINO ARGININE VASOPRESSIN; HEMORRHAGE; HUMANS;

EID: 0033926486     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2000.00059.x     Document Type: Review

References (66)

1. Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A. DDAVP. A new pharmacological approach to the management of hemophilia and von Willebrand disease. Lancet 1977; 1: 869.
2. Mannucci PM. Desmopressin. A non transfusional agent. Annu Rev Med 1990; 41: 55.
3. Schulman S. DDAVP. The multipotent drug in patients with coagulopathies. Transf Med Rev 1991; 5: 132.
4. Lethagen S. Desmopressin (DDAVP) and haemostasis. Ann Hematol 1994; 69: 173.
5. Hewson W. Experimental inquiries. Part I. An inquiry into the properties of the blood, with remarks on some of its morbid appearances. In: Gulliver G. ed. The Works of William Hewson, FRS London, UK: The Sydenham Society, 1846.
6. Cannon WB, Gray H. Factors affecting the coagulation time of blood. II. The hastening or retarding of coagulation by adrenaline injections. Am J Physiol 1914; 34: 231.
7. Cannon WB, Mendenhall WL. Factors affecting the coagulation time of blood. IV. The hastening of coagulation in pain and emotional excitement. Am J Physiol 1914; 34: 251.
8. Marciniak E. The influence of adrenaline in blood coagulation. Acta Physiol Pol 1957; 8: 224.
9. Ingram GIC. Increase in antihemophilic globulin activity following infusion of adrenaline. J Physiol 1961; 156: 217.
10. Ingram GIC, Vaughan Jones R, Hershgold EJ, Denson KWE, Perkins JR. Factor VIII activity and antigen, platelet count and biochemical changes after adrenoceptor stimulation. Br J Haematol 1977; 35: 81.
11. Mannucci PM, Gagnatelli G, D'Alonzo R. Stress and blood coagulation. In: Brinkhous KM, Hinnom S. eds. Thrombosis: Risk Factors and Diagnostic Approaches p 105. Stuttgart, Germany. Schattauer-Verlag, 1972.
12. Cash JD, Gader AMA, de Costa J. The release of plasminogen activator and factor VIII by LVP, AVP, DDAVP, AT III, and OT in man. Br J Haematol 1974; 27: 363.
13. Mannucci PM, Aberg M, Nilsson IM, Robertson B. Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol 1975; 30: 81.
14. Warrier L, Lusher JM. DDAVP. A useful alternative to blood components in moderate hemophilia A and von Willebrand's disease. J Pediatr 1983; 102: 228.
15. Mariani G, Ciavarella N, Mazzucconi MG et al. Evaluation of the effectiveness of DDAVP in surgery and bleeding episodes in hemophilia and von Willebrand's disease. A study of 43 patients. Clin Lab Hematol 1984; 6: 229.
16. de la Fuente B, Kasper CK, Rickles FR, Hoyer LW. Response of patients with mild and moderate hemophilia A and von Willebrand disease to treatment with desmopressin. Ann Intern Med 1985; 103: 6.
17. Mannucci PM, Pareti FI, Holmberg L, Ruggeri ZM, Nilsson IM. Studies on the prolonged bleeding time in von Willebrand disease. J Lab Clin Med 1976; 88: 62.
18. Barnhart MI, Chen S, Lusher JM. DDAVP. Does the drug have a direct effect on the vessel wall. Thromb Res 1983; 31: 239.
19. Sakariassen KS, Cattaneo M, van der Berg A, Ruggeri ZM, Sixma JJ. DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood 1984; 64: 229.
20. Levi M, de Boer JP, Roem D, ten Cate JH, Hack CE. Plasminogen activation in vivo upon intravenous infusion of DDAVP Quantitative assessment of plasmin-alpha2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay. Thromb Haemost 1992; 67: 111.
21. Kanwar S, Woodman RC, Poon MC et al. Desmopressin induces endothelial P-selectin expression and leukocyte rolling in post-capillary venules. Blood 1995; 86: 2760.
22. Takeuchi M, Naguza H, Kanedu T. DDAVP and epinephrine induce changes in the localization of von Willebrand factor antigen in endothelial cells of human oral mucosa. Blood 1981; 72: 850.
23. Booyse EM, Osikowicz G, Fedr S. Effects of various agents on ristocetin-Willebrand factor activity in long-term cultures of von Willebrand and normal human umbilical vein endothelial cells. Thromb Haemost 1981; 46: 668.
24. Hashemi S, Tackaberry ES, Palmer DS, Rock G, Ganz PR. DDAVP-induced release of von Willebrand factor from endothelial cells in vitro: The effect of plasma and blood cells. Biochim Biophys Acta 1990; 1052: 63.
25. Hashemi S, Palmer DS, Aye MT, Ganz PR. Platelet activating factor secreted by DDAVP-treated monocytes mediates von Willebrand factor release from endothelial cells. J Cell Physiol 1993; 154: 496.
26. Kobrinsky ML, Doyle JJ, Israel ED et al.Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus. Lancet 1985; 1: 1293.
27. Ibbotson SH, Davies JA, Grant PJ. The influence of infusions of 1-desamino-8-D-arginine vasopressin (DDAVP) in vivo on thrombin generation in vitro. Thromb Haemost 1992; 68: 37.
28. Ruggeri ZM, Mannucci PM, Lombardi R, Federici AB, Zimmerman TS. Multimeric composition of factor VIII/ von Willebrand factor following administration of DDAVP. Implications for pathophysiology and therapy of von Willebrand's disease subtypes. Blood 1982; 58: 1272.
29. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellum JD. Involvement of large plasma von Willebrand factor (VEF) multimers and unusually large VWF forms derived from endothelial cells in shear-stress induced platelet aggregation. J Clin Invest 1986; 78: 1456.
30. Tsai J-M, Sussman II, Nagel RL, Kaul DK. Desmopressin induces adhesion of normal human erythrocytes to the endothelial surface of a perfused microvascular preparation. Blood 1990; 75: 261.
31. Setty BNY, Dampier CD, Stuart MJ. 1-Deamino-8-D-arginine vasopressin decreases the production of 13-hydroxyoctadecadienoic acid by endothelial cells. Thromb Res 1992; 67: 545.
32. Mannucci PM, Bettega D, Cattaneo M. Patterns of development of tachyphylaxis in patients with hemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP). Br J Haematol 1992; 82: 87.
33. Gralnick HR, William SB, McKeon LP et al. DDAVP in type IIa von Willebrand's disease. Blood 1986; 67: 465.
34. Holmberg L, Nilsson IM, Borge L, Gunnarson M, Sjorin E. Platelet aggregation induced by 1-deamino-8-D-arginine vasopressin (DDAVP) in type IIB von Willebrand's disease. N Engl J Med 1983; 309: 816.
35. Castaman G, Rodeghiero F, Desmopressin and type IIB. von Willebrand disease. Hemophilia 1996; 2: 73.
36. Rodeghiero F, Castaman G, Mannucci PM. Prospective multicenter study of subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A. Thromb Haemost 1996; 76: 692.
37. Rose EH, Aledort LM. Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease. Ann Intern Med 1991; 114: 563.
38. Wun T, Paglieroni TG, Lachant NA. Desmopressin stimulates the expression of P-selectin on human platelets in vitro. J Lab Clin Med 1995; 125: 40.
39. Di Michele DM, Hathaway WE. Use of DDAVP in inherited and acquired platelet dysfunction. Am J Hematol 1990; 33: 39.
40. Rao AK, Ghosh S, Sum L et al. Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo controlled trial. Thromb Haemost 1995; 74: 1071.
41. Mannucci PM, Ghirardini A. Desmopressin twenty years after. Thromb Haemost 1997; 78: 958.
42. Mannucci PM, Remuzzi G, Pusineri F et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983; 308: 8.
43. Livio M, Mannucci PM, Viganò G et al. Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 1986; 315: 731.
44. Moia M, Mannucci PM, Vizzotto L, Casati S, Cattaneo M, Ponticelli C. Improvement in the hemostatic defect of uremia after treatment with recombinant human erythropoietin. Lancet 1987; 2: 1227.
45. Burroughs AK, Matthews K, Qadiri M et al. Desmopressin and bleeding time in patients with cirrhosis. Br J Med 1985; 291: 1377.
46. Mannucci PM, Vicente V, Vianello L et al. Controlled trial of desmopressin (DDAVP) in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood 1986; 67: 1148.
47. de Franchis F, Arcidiacono PG, Carpinelli PG et al. Randomized controlled trial of desmopressin plus terlipressin and terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter double blind study. Hepatology 1993; 18: 1102.
48. Schulman S, Johnsson H. Heparin. DDAVP and the bleeding time. Thromb Hemost 1991; 65: 242.
49. Johnstone MT, Andrews T, Ware JA et al. Bleeding time prolongation with streptokinase and its reduction with 1-deamino-8-D-arginine vasopressin. Circulation 1990; 82: 2142.
50. Bove CM, Casey B, Marder VJ. DDAVP reduces bleeding during continued hirudin administration in the rabbit. Thromb Haemost 1996; 75: 471.
51. Flordal PA, Ljungstrom KG, Svensson J. Desmopressin reverses effects of dextran on von Willebrand factor. Thromb Hemost 1989; 61: 541.
52. Salzman EW, Weinstein MJ, Weintraub RM et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. N Engl J Med 1986; 314: 1402.
53. Rocha E, Llorens R, Paramo JA, Areas R, Cuesta B, Trenor A. Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass? Circulation 1988; 77: 1319.
54. Hackmann T, Gascoyne R, Naiman SC et al. A trial of desmopressin to reduce blood loss in uncomplicated cardiac surgery. N Engl J Med 1989; 321: 1437.
55. Anderson TL, Solem JO, Tengborn L, Vinge E. Effects of desmopressin acetate on platelet aggregation von Willebrand factor and blood loss after cardiac surgery with extracorporeal circulation. Circulation 1990; 81: 872.
56. Sean MD, Wadsworth LD, Rogers PC. The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. J Thorac Cardiovasc Surg 1988; 48: 217.
57. Cattaneo M, Harris AS, Stromberg U, Mannucci PM. The effect of desmopressin on reducing blood loss in cardiac surgery. A meta-analysis of double-blind placebo-controlled trials. Thromb Haemost 1988; 74: 1064.
58. Horrow JC, van Riper DF, Strong MD, Brodsky I, Parmet JL. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation 1991; 84: 2063.
59. Rocha E, Hidalgo F, Llorens R, Melero JM, Arroyo SL, Paramo JA. Randomized trial of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary surgery. Circulation 1994; 90: 921.
60. Aron KV, Emery RW. Decreased postoperative drainage with addition of epsilonaminocaproic acid before cardiopulmonary bypass. Ann Thorac Surg 1994; 57: 1108.
61. Fremes SE, Wong BI, Lee E et al. Meta-analysis of prophylactic drug treatment in the prevention of postoperative bleeding. Ann Thorac Surg 1994; 58: 1580.
62. Kobrinsky NL, Letts RP, Patel R et al. DDAVP shortens the bleeding time and decreases blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Ann Intern Med 1987; 107: 446.
63. Guay J, Rainberg C, Poitras B et al. Trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesth Analg 1992; 75: 405.
64. Karnezis TA, Stulberg SD, Wixson RL, Reilly P. The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double-blind randomized trial. J Bone Joint Surg Am 1994; 76: 1545.
65. Haith LR, Patton ML, Goldman WT, McCutchan KM. Diminishing blood loss after operation for burns. Surg Gynaecol Obstet 1993; 176: 119.
66. AHCPR. Acute Pain Management. Operative or Medical Procedures and Trauma (Agency for Health Care Policy and Research Publications). Bethesda, MD: US Department of Health and Human Services 1992.